Protein arginine methyltransferases (PRMTs) as therapeutic targets

Expert Opinion on Therapeutic Targets

Volumn 16, Issue 7, 2012, Pages 651-664

  Cha, Boksik ^a   Jho, Eek Hoon ^a  

^a University of Seoul   (South Korea)

Author keywords

cancer; embryonic stem cells; epigenetic modification; PRMT; Wnt

Indexed keywords

BETA CATENIN; ENZYME INHIBITOR; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE INHIBITOR; STILBAMIDINE; UNCLASSIFIED DRUG; WNT PROTEIN;

CARCINOGENESIS; DRUG EFFECT; DRUG POTENCY; DRUG TARGETING; EMBRYONIC STEM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; EMBRYONIC STEM CELLS; HUMANS; NEOPLASMS; PROTEIN-ARGININE N-METHYLTRANSFERASES; WNT PROTEINS;

EID: 84862551032     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2012.688030     Document Type: Review

References (105)

1. Paik WK, Paik DC, Kim S. Historical review: the field of protein methylation. Trends Biochem Sci 2007;32:146-52 (Pubitemid 46367693)
2. McBride AE, Silver PA. State of the arg: protein methylation at arginine comes of age. Cell 2001;106:5-8 (Pubitemid 32709951)
3. Bedford MT, Clarke SG. Protein arginine methylation in mammals: who, what, and why. Mol Cell 2009;33:1-13 This review provides comprehensive information about a variety of biological roles of PRMT family and well organizes its substrates.
4. Boisvert FM, Chenard CA, Richard S. Protein interfaces in signaling regulated by arginine methylation. Sci STKE 2005;2005:re2
5. Chang B, Chen Y, Zhao Y, et al. JMJD6 is a histone arginine demethylase. Science 2007;318:444-7 (Pubitemid 47614528)
6. Hong X, Zang J, White J, et al. Interaction of JMJD6 with single-stranded RNA. Proc Natl Acad Sci USA 2010;107:14568-72
7. Cook JR, Lee JH, Yang ZH, et al. FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues. Biochem Biophys Res Commun 2006;342:472-81 (Pubitemid 43289016)
8. Miranda TB, Miranda M, Frankel A, et al. PRMT7 is a member of the protein arginine methyltransferase family with a distinct substrate specificity. J Biol Chem 2004;279:22902-7 (Pubitemid 38685591)
9. Zurita-Lopez CI, Sandberg T, Kelly R, et al. Human Protein Arginine Methyltransferase 7 (PRMT7) Is a Type III enzyme forming omega-NG-Monomethylated arginine residues. J Biol Chem 2012;287:7859-70
10. Sun L, Wang M, Lv Z, et al. Structural insights into protein arginine symmetric dimethylation by PRMT5. Proc Natl Acad Sci USA 2011;108:20538-43 This paper provides an explantion how arginine methyltransferases determine the specificity of symmetric or asymmetric dimethylation.
11. Zhang X, Cheng X. Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. Structure 2003;11:509-20 (Pubitemid 36579129)
12. Yue WW, Hassler M, Roe SM, et al. Insights into histone code syntax from structural and biochemical studies of CARM1 methyltransferase. EMBO J 2007;26:4402-12 (Pubitemid 47587659)
13. Troffer-Charlier N, Cura V, Hassenboehler P, et al. Functional insights from structures of coactivator-associated arginine methyltransferase 1 domains. EMBO J 2007;26:4391-401 (Pubitemid 47587658)
14. Ubersax JA, Ferrell JE Jr. Mechanisms of specificity in protein phosphorylation. Nat Rev Mol Cell Biol 2007;8:530-41 (Pubitemid 46985383)
15. Wooderchak WL, Zang T, Zhou ZS, et al. Substrate profiling of PRMT1 reveals amino acid sequences that extend beyond the "RGG" paradigm. Biochemistry 2008;47:9456-66
16. Osborne TC, Obianyo O, Zhang X, et al. Protein arginine methyltransferase 1: positively charged residues in substrate peptides distal to the site of methylation are important for substrate binding and catalysis. Biochemistry 2007;46:13370-81 (Pubitemid 350136376)
17. Cheng D, Cote J, Shaaban S, et al. The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Mol Cell 2007;25:71-83 (Pubitemid 46049059)
18. Pahlich S, Zakaryan RP, Gehring H. Protein arginine methylation: cellular functions and methods of analysis. Biochim Biophys Acta 2006;1764:1890-903
19. Lin WJ, Gary JD, Yang MC, et al. The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem 1996;271:15034-44 (Pubitemid 26197578)
20. Robin-Lespinasse Y, Sentis S, Kolytcheff C, et al. hCAF1, a new regulator of PRMT1-dependent arginine methylation. J Cell Sci 2007;120:638-47 (Pubitemid 46437898)
21. Singh V, Miranda TB, Jiang W, et al. DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo. Oncogene 2004;23:7761-71 (Pubitemid 39457026)
22. Friesen WJ, Wyce A, Paushkin S, et al. A novel WD repeat protein component of the methylosome binds Sm proteins. J Biol Chem 2002;277:8243-7 (Pubitemid 34968281)
23. Aggarwal P, Vaites LP, Kim JK, et al. Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. Cancer Cell 2010;18:329-40
24. Liu F, Zhao X, Perna F, et al. JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation. Cancer Cell 2011;19:283-94 This paper provides a novel mechanism for the regulation of PRMT activity and JAK2-induced oncogenesis.
25. Frankel A, Yadav N, Lee J, et al. The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity. J Biol Chem 2002;277:3537-43 (Pubitemid 34953224)
26. Sayegh J, Webb K, Cheng D, et al. Regulation of protein arginine methyltransferase 8 (PRMT8) activity by its N-terminal domain. J Biol Chem 2007;282:36444-53
27. Kuhn P, Xu Q, Cline E, et al. Delineating Anopheles gambiae coactivator associated arginine methyltransferase 1 automethylation using top-down high resolution tandem mass spectrometry. Protein Sci 2009;18:1272-80
28. Kuhn P, Chumanov R, Wang Y, et al. Automethylation of CARM1 allows coupling of transcription and mRNA splicing. Nucleic Acids Res 2011;39:2717-26
29. Higashimoto K, Kuhn P, Desai D, et al. Phosphorylation-mediated inactivation of coactivator-associated arginine methyltransferase 1. Proc Natl Acad Sci USA 2007;104:12318-23 It provides an example for the regulation of protein arginine methyltransferase activity. (Pubitemid 47206135)
30. Feng Q, He B, Jung SY, et al. Biochemical control of CARM1 enzymatic activity by phosphorylation. J Biol Chem 2009;284:36167-74
31. Avila MA, Garcia-Trevijano ER, Lu SC, et al. Methylthioadenosine. Int J Biochem Cell Biol 2004;36:2125-30 (Pubitemid 39094435)
32. Zheng YG, Wu J, Chen Z, et al. Chemical regulation of epigenetic modifications: opportunities for new cancer therapy. Med Res Rev 2008;28:645-87
33. Cheng D, Yadav N, King RW, et al. Small molecule regulators of protein arginine methyltransferases. J Biol Chem 2004;279:23892-9 It is the first study for the identification of PRMT inhibitors through high-throughput screening. (Pubitemid 38725246)
34. Mai A, Valente S, Cheng D, et al. Synthesis and biological validation of novel synthetic histone/protein methyltransferase inhibitors. ChemMedChem 2007;2:987-91
35. Ragno R, Simeoni S, Castellano S, et al. Small molecule inhibitors of histone arginine methyltransferases: homology modeling, molecular docking, binding mode analysis, and biological evaluations. J Med Chem 2007;50:1241-53 (Pubitemid 46496324)
36. Spannhoff A, Heinke R, Bauer I, et al. Target-based approach to inhibitors of histone arginine methyltransferases. J Med Chem 2007;50:2319-25 (Pubitemid 46799244)
37. Heinke R, Spannhoff A, Meier R, et al. Virtual screening and biological characterization of novel histone arginine methyltransferase PRMT1 inhibitors. ChemMedChem 2009;4:69-77
38. Purandare AV, Chen Z, Huynh T, et al. Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1). Bioorg Med Chem Lett 2008;18:4438-41
39. Huynh T, Chen Z, Pang S, et al. Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1). Bioorg Med Chem Lett 2009;19:2924-7 This paper provides a good example of systematic optimization process for drug deveolpment.
40. Allan M, Manku S, Therrien E, et al. N-Benzyl-1-heteroaryl-3- (trifluoromethyl)-1H-pyrazole-5-carboxamides as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1). Bioorg Med Chem Lett 2009;19:1218-23 This paper provides a good example of systematic optimization process for drug deveolpment.
41. Therrien E, Larouche G, Manku S, et al. 1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1). Bioorg Med Chem Lett 2009;19:6725-32
42. Pawlak MR, Scherer CA, Chen J, et al. Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable. Mol Cell Biol 2000;20:4859-69 (Pubitemid 30396132)
43. Yu Z, Chen T, Hebert J, et al. A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation. Mol Cell Biol 2009;29:2982-96
44. Yoshimoto T, Boehm M, Olive M, et al. The arginine methyltransferase PRMT2 binds RB and regulates E2F function. Exp Cell Res 2006;312:2040-53 (Pubitemid 43850929)
45. Ganesh L, Yoshimoto T, Moorthy NC, et al. Protein methyltransferase 2 inhibits NF-kappaB function and promotes apoptosis. Mol Cell Biol 2006;26:3864-74 (Pubitemid 43726403)
46. Iwasaki H, Kovacic JC, Olive M, et al. Disruption of protein arginine N-methyltransferase 2 regulates leptin signaling and produces leanness in vivo through loss of STAT3 methylation. Circ Res 2010;107:992-1001
47. Swiercz R, Cheng D, Kim D, et al. Ribosomal protein rpS2 is hypomethylated in PRMT3-deficient mice. J Biol Chem 2007;282:16917-23 (Pubitemid 47093198)
48. Kongsuwan K, Yu Q, Vincent A, et al. A drosophila minute gene encodes a ribosomal protein. Nature 1985;317:555-8 (Pubitemid 16224168)
49. Choi S, Jung CR, Kim JY, et al. PRMT3 inhibits ubiquitination of ribosomal protein S2 and together forms an active enzyme complex. Biochim Biophys Acta 2008;1780:1062-9
50. Yadav N, Lee J, Kim J, et al. Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice. Proc Natl Acad Sci USA 2003;100:6464-8 (Pubitemid 36666604)
51. O'Brien KB, Alberich-Jorda M, Yadav N, et al. CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells. Development 2010;137:2147-56
52. Yadav N, Cheng D, Richard S, et al. CARM1 promotes adipocyte differentiation by coactivating PPARgamma. EMBO Rep 2008;9:193-8 (Pubitemid 351223458)
53. Kim J, Lee J, Yadav N, et al. Loss of CARM1 results in hypomethylation of thymocyte cyclic AMP-regulated phosphoprotein and deregulated early T cell development. J Biol Chem 2004;279:25339-44 (Pubitemid 38756789)
54. Tee WW, Pardo M, Theunissen TW, et al. Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency. Genes Dev 2010;24:2772-7
55. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7 (Pubitemid 28516247)
56. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-6 (Pubitemid 11050741)
57. Young RA. Control of the embryonic stem cell state. Cell 2011;144:940-54
58. Boiani M, Scholer HR. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 2005;6:872-84 (Pubitemid 41568736)
59. Yamanaka S. A fresh look at iPS cells. Cell 2009;137:13-17
60. Bannister AJ, Kouzarides T. Reversing histone methylation. Nature 2005;436:1103-6 (Pubitemid 41232281)
61. Schurter BT, Koh SS, Chen D, et al. Methylation of histone H3 by coactivator-associated arginine methyltransferase 1. Biochemistry 2001;40:5747-56 (Pubitemid 32440879)
62. Torres-Padilla ME, Parfitt DE, Kouzarides T, et al. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature 2007;445:214-18 This study describes CARM1's role in the regulation of cell fate determination. (Pubitemid 46095726)
63. Parfitt DE, Zernicka-Goetz M. Epigenetic modification affecting expression of cell polarity and cell fate genes to regulate lineage specification in the early mouse embryo. Mol Biol Cell 2010;21:2649-60
64. Wu Q, Bruce AW, Jedrusik A, et al. CARM1 is required in embryonic stem cells to maintain pluripotency and resist differentiation. Stem Cells 2009;27:2637-45
65. Calvanese V, Lara E, Suarez-Alvarez B, et al. Sirtuin 1 regulation of developmental genes during differentiation of stem cells. Proc Natl Acad Sci USA 2010;107:13736-41
66. Pollack BP, Kotenko SV, He W, et al. The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J Biol Chem 1999;274:31531-42
67. Lee DY, Teyssier C, Strahl BD, et al. Role of protein methylation in regulation of transcription. Endocr Rev 2005;26:147-70
68. Ancelin K, Lange UC, Hajkova P, et al. Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. Nat Cell Biol 2006;8:623-30 (Pubitemid 43827356)
69. Wang J, Rao S, Chu J, et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006;444:364-8 Using proteomic approach authors provides a landscape of protein network for the maintenance of pluripotency of embryonic stem cells. (Pubitemid 44764111)
70. Kim J, Chu J, Shen X, et al. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008;132:1049-61 This paper provides more complete understanding of the regulatory network that maintains ES cells in a pluripotent state. (Pubitemid 351381745)
71. Matsuda H, Shi YB. An essential and evolutionarily conserved role of protein arginine methyltransferase 1 for adult intestinal stem cells during postembryonic development. Stem Cells 2010;28:2073-83
72. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007;1:39-49 (Pubitemid 46865811)
73. Saha K, Jaenisch R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 2009;5:584-95
74. Yuan X, Wan H, Zhao X, et al. Brief report: combined chemical treatment enables oct4-induced reprogramming from mouse embryonic fibroblasts. Stem Cells 2011;29:549-53
75. Teyssier C, Le Romancer M, Sentis S, et al. Protein arginine methylation in estrogen signaling and estrogen-related cancers. Trends Endocrinol Metab 2010;21:181-9
76. Cha B, Kim W, Kim YK, et al. Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling. Oncogene 2011;30:2379-89
77. Blythe SA, Cha SW, Tadjuidje E, et al. Beta-Catenin primes organizer gene expression by recruiting a histone H3 arginine 8 methyltransferase, Prmt2. Dev Cell 2010;19:220-31 This paper shows for the first time that expression of b-catenin dependent gene expression in early embryonic development can be regulated by PRMT.
78. Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 1997;11:3286-305 (Pubitemid 28023954)
79. Moon RT, Brown JD, Torres M. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 1997;13:157-62 (Pubitemid 27191521)
80. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-51 (Pubitemid 30639518)
81. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000;103:311-20
82. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009;17:9-26 This paper reviews comprehensive overview of Wnt signaling pathway.
83. Mosimann C, Hausmann G, Basler K. Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat Rev Mol Cell Biol 2009;10:276-86
84. Koh SS, Li H, Lee YH, et al. Synergistic coactivator function by coactivator-associated arginine methyltransferase (CARM) 1 and beta-catenin with two different classes of DNA-binding transcriptional activators. J Biol Chem 2002;277:26031-5 (Pubitemid 34967085)
85. Xu W, Chen H, Du K, et al. A transcriptional switch mediated by cofactor methylation. Science 2001;294:2507-11 (Pubitemid 34027283)
86. Chevillard-Briet M, Trouche D, Vandel L. Control of CBP co-activating activity by arginine methylation. EMBO J 2002;21:5457-66 (Pubitemid 35231025)
87. Ou CY, Labonte MJ, Manegold PC, et al. A coactivator role of CARM1 in the Dysregulation of {beta}-Catenin activity in colorectal cancer cell growth and gene expression. Mol Cancer Res 2011;9:660-70
88. Bikkavilli RK, Malbon CC. Arginine methylation of G3BP1 in response to Wnt3a regulates {beta}-catenin mRNA. J Cell Sci 2011;124:2310-20
89. Seligson DB, Horvath S, Shi T, et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005;435:1262-6 (Pubitemid 40943093)
90. Mathioudaki K, Papadokostopoulou A, Scorilas A, et al. The PRMT1 gene expression pattern in colon cancer. Br J Cancer 2008;99:2094-9
91. Mathioudaki K, Scorilas A, Ardavanis A, et al. Clinical evaluation of PRMT1 gene expression in breast cancer. Tumour Biol 2011;32:575-82
92. Yoshimatsu M, Toyokawa G, Hayami S, et al. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers. Int J Cancer 2011;128:562-73
93. Daser A, Rabbitts TH. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Semin Cancer Biol 2005;15:175-88
94. Cheung N, Chan LC, Thompson A, et al. Protein arginine-methyltransferase- dependent oncogenesis. Nat Cell Biol 2007;9:1208-15 This report demonstrates that PRMT is involved in MLL-mediated oncogenesis. (Pubitemid 47500498)
95. Le Romancer M, Treilleux I, Leconte N, et al. Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol Cell 2008;31:212-21 (Pubitemid 352005820)
96. Majumder S, Liu Y, Ford OH III, et al. Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability. Prostate 2006;66:1292-301 (Pubitemid 44384306)
97. Hong H, Kao C, Jeng MH, et al. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostatecarcinoma and androgen-independent status. Cancer 2004;101:83-9 (Pubitemid 38812426)
98. El Messaoudi S, Fabbrizio E, Rodriguez C, et al. Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene. Proc Natl Acad Sci USA 2006;103:13351-6 (Pubitemid 44380111)
99. Kim YR, Lee BK, Park RY, et al. Differential CARM1 expression in prostate and colorectal cancers. BMC Cancer 2010;10:197
100. Metivier R, Penot G, Hubner MR, et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003;115:751-63 (Pubitemid 38030303)
101. Chen D, Huang SM, Stallcup MR. Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300. J Biol Chem 2000;275:40810-16 (Pubitemid 32054901)
102. Frietze S, Lupien M, Silver PA, et al. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. Cancer Res 2008;68:301-6 (Pubitemid 351380132)
103. Al-Dhaheri M, Wu J, Skliris GP, et al. CARM1 is an important determinant of ERalpha-dependent breast cancer cell differentiation and proliferation in breast cancer cells. Cancer Res 2011;71:2118-28
104. Pal S, Baiocchi RA, Byrd JC, et al. Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma. EMBO J 2007;26:3558-69 (Pubitemid 47236878)
105. Pal S, Vishwanath SN, Erdjument-Bromage H, et al. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 2004;24:9630-45 (Pubitemid 39391698)